�ϰ������ϲʿ�����¼����

Desrues, T.; Merad, J.; Andrei, D.; Pons, J-M.; Parrain, J-L.; Médebielle, M.; Quintard, A.; Bressy, C. ” Impact of the Difluoromethylene Group in the Organocatalyzed Acylative Kinetic Resolution of α,α-Difluorohydrins” Angewandte Chemie, International Edition, 2021, 60 (47), 24924-24929

Puglisi, M.P.; Bradaric, M. J.; Pontikis, J.; Cabai, J.; Weyna, T.; Tednes, P.; Schretzman, R.; Rickert, K.; Cao, Z.; Andrei, D.* “Novel primary amine diazeniumdiolates - chemical and biological characterization” Drug Development Research, 2018, 79, 136-143. *Corresponding author

Bharadwaj, G.; Benini, P. G.Z.; Basudhar, D.; Ramos-Colon C. N.; Johnson G. M.; Larriva, M. M.; Keefer, L. K.; Andrei, D.; Miranda, K. M.:”Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates” Nitric Oxide, 2014, 42, 70–78

Andrei, D.; Salmon, J.D.; Donzelli, S.; Wahab, A.; Citro. M.; Saavedra, J.E.;Miranda, K.M.; Keefer, L. K. “Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class”, Journal of American Chemical Society 2010, 132, 16526-16532.

Andrei, D.*;Maciag, A.E; Chakrapani, H.; Citro, M.L.; Keefer, L. K.; Saavedra, J. E.; ”Aryl Bis(diazeniumdiolates): Potent Inducers of S-Glutathionylation of Cellular Proteins and Their in Vitro Antiproliferative Activities”, Journal of Medicinal Chemistry, 2008, 51(24), 7944-7952. *Corresponding author.